Disturbances in the nitric oxide (NO) vasodilatory pathway have been implicated in acute vasoconstriction and ischemia after subarachnoid hemorrhage (SAH). The authors hypothesize that blood released during SAH leads to vasocon striction by scavenging NO and limiting its availability. This was tested by measuring the major NO metabolites nitrite and nitrate in five different brain regions before and after experi mental SAH. The basal NO metabolites levels were as follows (mean ± SO, f.Lmol/mg wet weight): brain stem, 0.14 ± 0.07; cerebellum, 0.12 ± 0.08; ventral convexity cortex, 0.22 ± 0.15; dorsal convexity cortex, 0.16 ± 0.11; and hippocampus, 0.26 ± 0.17. In sham-operated animals, no effect of the nitric oxide synthase (NOS) inhibitor L G -nitro-L-arginine-methyl-ester (30 mg/kg) was found on NO metabolites 40 minutes after admin istration, but a significant decrease was seen after 120 minutes.
Cerebral blood flow decreases acutely and ischemic injury occurs after subarachnoid hemorrhage (SAH) in both experimental and clinical studies. Cerebral arteries have been shown to respond to SAH with a biphasic constriction. An acute constriction begins minutes after the bleed, and delayed vasospasm begins 48 hours later . Although the significance of de layed vasospasm is recognized (Sobey and Faraci, 1998) the contribution of acute vasoconstriction to ischemic brain damage after SAH is less clear (Bederson et a!., 1998; Schwartz et a!., 1999; . Differ ent mechanisms may underlie the two processes, and
The NO metabolites decreased significantly 10 minutes after SAH in all brain regions except for hippocampus, and recov ered to control levels in cerebellum at 60 minutes and in brain stem and dorsal cerebral cortex 180 minutes after SAH, while remaining low in ventral convexity cortex. Nitrite recovered completely in all brain regions at 180 minutes after SAH, whereas nitrate remained decreased in brain stem and ventral convexity cortex. Our results indicate that SAH causes acute decreases in cerebral NO levels by a mechanism other than NOS inhibition and provide further support for the hypothesis that alterations in the NO vasodilatory pathway contribute di rectly to the ischemic insult after SAH. Key Words: Subarach noid hemorrhage-Acute vasoconstriction-Griess reaction Nitric oxide-Nitric oxide synthase inhibitor. numerous mechanisms have been proposed (Delgado et a!., 1988; Edwards et a!., 1992; Svendgaard et a!., 1987; Well urn et a!., 1985; Willette et a!., 1997) .
Resting cerebrovascular tone and blood flow are main tained by a balance between opposing vasoconstrictive and vasodilatory forces. One of the most important of these is the resting vasodilatory influence of nitric oxide (NO) . NO has been shown to induce endothelium dependent vasodilation through a cGMP-mediated mechanism (Rapoport and Murad, 1983) . Decreased cGMP production (Kim et a!., 1989; Kim et a!., 1992) and loss of endothelium-mediated vasodilation (Kim et a!., 1988; Nakagomi et a!. 1987) contributes to delayed vasospasm after SAH. Furthermore, NO also may cause hyperpolarization and vessel relaxation through a cGMP independent activation of potassium channels (Bolotina et a!., 1994) .
Acute constriction of cerebral blood vessels after SAH may result from inhibition of the vasodilatory influence of NO. This is supported by our recent findings that administration of NO donor can reverse acute vasocon striction and restore CBF after SAH . Because both the vasodilatory mechanism and the NO synthesizing ability of cerebral blood vessels are pre served after SAH (Kajita et aI., 1994; Kim et aI., 1989; Sehba et aI., 1999) , acute vasoconstriction observed after SAH may indicate a decrease in cerebral NO levels that leads to unopposed vasoconstriction. Hemoglobin has a high binding affinity for NO (Macdonald and Weir, 199 1) . Blood released in the subarachnoid space may scavenge NO, decreasing its availability to blood vessels (Afshar et aI., 1995; Kajita et aI., 1994; Sehba et aI., 1999; Watkins, 1995) . However, no direct supporting evidence has been presented. If SAH causes decreased NO availability, this should be detectable by measuring NO or its metabolites.
Several techniques have been used to measure NO content in brain. The three most commonly used tech niques include the Griess reaction, the oxyhemoglobin assay, and NO microelectrodes (Malinski et aI., 1993; Williams et a!., 1997) . The Griess reaction is a spectro photometric assay that measures nitrite and nitrate, the two major metabolites of NO, after converting them into a diazo compound (Privat et aI., 1997) . It has been pre viously used to demonstrate an increase in NO produc tion during cerebral ischemia in rats (Kader et aI., 1993; Kumura et aI., 1994; Shibata et aI., 1996) .
The current study examines the effect of SAH on basal NO levels by measuring nitrite and nitrate in five differ ent regions of rat brain before and after SAH using the Griess reaction. Inhibition of NO synthesis by L G -nitro L-arginine-methyl-ester (L-NAME) was used to exam ined the capacity of Griess reaction to detect decreases in basal NO metabolites.
MATERIALS AND METHODS

Animal model of subarachnoid hemorrhage
Male Sprague-Dawley rats (350 to 420 g) underwent experi mental SAH using the endovascular suture model developed in this laboratory (Bederson et aI., 1995; Bederson et aI., 1995) .
Briet1y, rats were anesthetized with chloral hydrate (35 mg/kg intraperitoneally), transorally intubated, ventilated, and main tained on inspired halothane (0.5% to 0.75% in oxygen supplemented room air). Rats were positioned in a stereotaxic frame, and the femoral artery exposed and cannulated for blood gas and blood pressure (BP) monitoring. For measurement of intracranial pressure (ICP), the atlanto-occipital membrane was exposed and cannulated, and the cannula was affixed with methymethacrylate cement to a stainless steel screw implanted in the occipital bone (Barth et aI., 1992) . The (Bederson et aI., 1995) . Animals were monitored for 20 minutes before SAH and 10, 60, or ISO min utes after SAH. Sham-operated rats underwent a similar ex perimental procedure except for induction of SAH.
Brain preparation
After the experiment, animals were killed, and the brains were removed and placed on ice. Brains were divided in the midline. One hemisphere (the left side) was used for the assay.
In preliminary experiments, no significant difference in NO metabolite content was found between right and left hemi spheres. Five different brain regions (brain stem, cerebellum, ventral convexity cortex, dorsal convexity cortex, and hippo campus) were isolated. Tissues were quickly weighed and placed in boroscilicate glass tubes containing chilled phos phate-buffered saline, volume 10 times the tissue weight. Tis sues were homogenized on ice using a tissue homogenizer (Tis sumizer, Tekmar, Cincinnati, OH, U.S.A.). The homogenate was centrifuged at 10,000 x g for 20 minutes. The supernatant was collected and centrifuged again at 75,000 x g for 15 min utes. A total of 500 fLL of supernatant was filtered through a micron filter system (Microcon YM-30, Amicon Inc. Beverly, MA, U.S.A.) at 14,000 x g for 20 minutes to eliminate proteins above 30,000-kDa molecular weight, which may interfere with the absorbance of nitrite. Fi ltrate was collected and refrigerated at 4°C until use. In preliminary experiments, refrigeration of the filtrate did not affect NO-2/NO-3 measurements, whereas freezing brain tissues or filtrate decreased the contents of NO metabolites.
Measurement of NO metabolite levels
The measurements were performed using a NitratelNitrite Nitrite contents of the sample (100 fLL) were determined by reading absorbance after adding Griess reagents in the absence of nitrate reductase. Subtraction of nitrite values from the total NO metabolites allowed quantification of nitrate. All measure ments were performed in duplicate.
Drug treatment
Animals were divided into six groups. Group 1 (n = 9) underwent sham operation and was observed for 15 minutes before killing and brain removal. Groups 2 (n = 6) and 3 (n = 5) underwent sham operation followed by intravenous injection of L-NAME (30 mg/kg, Sigma, St. Louis, MO, U.S.A.) and 40 or 120 minutes of recording, respectively. Groups 4 (n = 6) and 5 (n = 5) underwent SAH and physiologic recording for 10 or 60 minutes before killing and brain removal, respectively.
Group 6 (n = 6) underwent limited surgery to optimize sur vival. In this group, CBF was recorded for 10 minutes before and 10 minutes after the SAH to ensure the intensity of hem orrhage, but no other physiologic measurements (i.e., ICP, BP) were made. To optimize the number of animals in the study, we used one set of control animals for comparison with the L NAME and SAH groups. Because SAH rats were not pretreated with saline, control animals did not receive saline.
Data acquisition and statistical analysis
Cerebral blood now, ICP, and mean arterial blood pressure data were continuously recorded starting 20 minutes before and 10 to 60 minutes after SAH using customized analog-to-digital conversion hardware and software (Labview v 4.0, National Instruments, Austin, TX, U.S.A.) and stored at a rate of 0.25
Hz. The CBF data were normalized to an average (baseline) value obtained for 10 minutes before SAH and expressed as a percentage of baseline. The NO metabolites were read from standard curves and divided by the wet tissue weight and ex pressed as fLmol/mg wet tissue weight. Statistical evaluation was performed using a one-way analysis of variance followed by Bonferroni post hoc test setting significance at P < 0.05.
RESULTS
Standardization of the Griess reaction for cerebral NO metabolites detection and quantification
The efficiency of the Griess reaction to detect changes in NO metabolites levels would be limited if the quantity of metabolite is outside of the minimum or maximum sensitive range of the assay. The absorbance-to-volume ratio using increasing volumes of brain tissue filtrate (20, 40, 60 , and 80 f.1L) was therefore studied. A linear in crease in absorbance at 540 nm was found with increas ing quantity of brain tissue homogenate for all the re gions assayed ( Fig. I A) . A volume of 50 f.1L was used for the subsequent experiments, since absorbance by this volume would fall in the middle of linear portion of the graph.
Analytic recovery of NO metabolites theoretically .05
could be affected by the presence of substances in brain filtrates that interfere with the activity of nitrate reduc tase or have absorbance near 540 nm. This was investi gated by creating a standard curve of nitrate in presence or absence of a fixed amount of brain tissue filtrate.
Because it was assumed that filtrate from all six regions of brain would act in a similar manner, dorsal convexity cortex from a control animal was used for this experi ment. A linear increase in absorbance was found with increasing concentration of nitrate in the presence or ab sence of cerebral cortex filtrate, indicating the analytical capability of the assay to accurately measure nitrate con tent (Fig. IB) .
The basal NO metabolites levels per wet tissue weight were as follows (f.1mol/mg wet tissue weight, mean ± SD): brain stem, 0.14 ± 0.07; cerebellum, 0. 12 ± 0.08; ventral convexity cortex, 0.22 ± 0. 15; dorsal convexity cortex, 0.16 ± 0. 11; and hippocampus, 0.26 ± 0.15. Basal nitrite and nitrate levels also were determined. The high est nitrite and nitrate levels were found in the hippocam pus (0.04 ± 0.01, and 0.23 ± 0. 17 f.1mol/mg wet tissue weight, respectively) and lowest in the cerebellum (0.01 ± 0.008, and 0.11 ± 0.08 f.1mol/mg wet tissue weight, respectively, Fig. 2 ).
Effects of nitric oxide synthase inhibition on physiology and NO metabolites
At 40 or 120 minutes before killing and brain removal, L-NAME was administered in sham-operated animals. The BP increased within 1 minute after administration of L-NAME, reaching a maximum value 20 minutes after injection (from 93.9 ± 10.7 to 13 1.4 ± 17.3 mm Hg). During the same time period, CBF decreased to 66.6 ± 9.0% of control and remained near this level for the duration of the experiments (Fig. 3A) . No significant effect on ICP was found. Physiologic effects of L-NAME persisted for at least 120 minutes (Fig. 3B) . Administration of L-NAME had no effect on total NO metabolite levels in the brain regions tested 40 minutes after administration (P > 0.05). However, 120 minutes after administration, a significant decrease in NO me tabolite levels was found in the brain stem, cerebellum, ventral convexity cortex, and dorsal convexity cortex (P < 0.05) but not in the hippocampus (Fig. 4A) . A signifi cant decrease in nitrite was found 120 minutes after L-NAME administration in all brain regions tested Time (minutes) 150 (P < 0.05; Fig. 4B ). Nitrate levels were significantly decreased in brain stem, cerebellum, and ventral and dor sal convexity cortex (P < 0.05) but not in hippocampus (P > 0.05, Fig. 4C ) .
Effect of subarachnoid hemorrhage on cerebral levels of NO metabolites
Animals were killed 10 minutes (group 4, n = 6), 60 minutes (group 5, n = 5), or 180 minutes (group 6, n = 6) after SAH induction. At the time of SAH induction, arterial blood Pco 2 was 40 ± 5 mm Hg; Po 2 , 14 1 ± 29 mm Hg; and the pH, 7.4 ± 0. 1. The blood gases were maintained throughout the experiment. After SAH induc tion, CBF decreased to 1.0 ± 0.7% of baseline acutely (within 1 minute) and recovered to 9.5 ± 4.4% of base line 10 minutes later. Baseline ICP was 3.7 ± 1.8 mm Hg and rose to 78. 1 ± 37.8 mm Hg immediately after SAH, followed by a decrease to 35.5 ± 30.2 mm Hg 10 minutes later. The BP was not significantly affected (from 105.9 ± 9. 1 to 115.5 ± 18.9 mm Hg, Fig. SA) . A significant decrease in NO metabolite levels was found in all brain regions (P < 0.05, Fig. 6A ) except for hippocampus 10 minutes after SAH. Nitrite levels were decreased signifi cantly in brain stem, ventral convexity cortex, and hip pocampus, whereas a trend toward decrease was found in brain stem (P = 0.055), cerebellum (P = 0.06 1), and dorsal convexity cortex (P = 0.065; Fig. 6B ). Nitrate levels were significantly decreased in brain stem, cer ebellum, and ventral convexity cortex (P < 0.05) but not in hippocampus. A trend toward decreased nitrate levels was found in dorsal convexity cortex (P = 0.065; Fig.  6C ). In group 5, CBF decreased to 3. 1 ± 1.4% acutely and recovered to 35.8 ± 26.0% 60 minutes after SAH (Fig. 5B ). Sixty minutes after SAH, total NO metabolite levels were significantly decreased in brain stem and dorsal and ventral convexity cortex (P < 0.05, Fig. 6A ) and had recovered to control levels in cerebellum ( 6B). In group 6, CBF decreased to 1.4 ± 1.3% acutely and recovered to 6.0 ± 5.7% 10 minutes after SAH (data not shown). One hundred eighty minutes after SAH, total NO metabolites remained decreased in ventral convexity cortex but had returned to baseline in rest of the brain regions. The recovery of total NO metabolite resulted from nitrite that increased to baseline levels in these brain regions. In contrast, nitrate levels remained signifi cantly decreased in the brain stem and ventral convexity Br.S eE vee Dee HI cortex, the areas that receive the maximum amount of blood after SAH (Fig. 6C ).
DISCUSSION
Pathologic alteration of the L-arginine-NO pathway in SAH previously has been suggested as a factor that con tributes to delayed vasospasm (Afshar et aI., 1995; Ed wards et aI., 1992; Pluta et aI., 1997; Suzuki et aI., 1994) . We hypothesize that disturbances in this pathway con tribute to acute vasoconstriction after SAH (Bederson et a!., 1998; Schwartz et a!., 1999; . However, little direct evidence of decreased NO avail ability in the acute phases of SAH has been presented.
Our study investigates the effect of SAH on NO by mea suring its two major metabolites, nitrite and nitrate, in five brain regions before and after SAH induction. We found that NO levels declined acutely (within 10 min utes) after SAH and recovered in four of the regions 180 minutes after SAH. This is the first demonstration of the effect of SAH on cerebral NO levels. Both global and focal cerebral ischemia cause an in crease in cerebral NO levels that can be attenuated by nitric oxide synthase (NOS) inhibitors, indicating that increased NOS activity is the source of ischemic NO overproduction (Kader et a!., 1993; Kumura et a!., 1994; Malinski et a!., 1993; Shibata et a!., 1996) . Decreased NO levels observed in the current study makes SAH unique among the various forms of ischemic insults (Kader et a!., 1993; Kumura et a!., 1994; Malinski et a!., 1993 ). An initial decrease in NO availability may con tribute to SAH-induced brain injury by initiating a series of events including unopposed vasoconstriction, de creased CBF, ischemia, and glutamate release (Bederson et a!., 1995; Bederson et a!., 1998; Schwartz et aI., 1999; as well as Ca+ 2 influx, activation of NOS, and subsequently increased NO production.
B
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• SAH (60 min) Subarachnoid hemorrhage induces an acute global ischemic insult (Bederson et a!., 1998) , which is the pri mary cause of morbidity and mortality in humans (Bro derick et a!., 1994; Kassell et a!., 1985) . We previously demonstrated that acute cerebral vasoconstriction con tributes to this ischemia (Bederson et aI., 1998) and that decreased NO availability plays important role in this process (Schwartz et a!., 1999; .
Although our sample collection technique excluded blood vessels of the Circle of Willis, it is presumed that measured NO was produced by both neuronal and endo thelial NOS. Other investigators have found both NOS isoforms in neuronal tissues (Dinerman et a!., 1994) . Se lection of brain regions for the current study was based on their anatomic location in relation to blood distribu tion in the subarachnoid space (Bederson et a!., 1995; Sehba et aI., 1999) . Nitric oxide metabolite levels were reduced more in areas exposed to the most blood (ventral convexity cortex and brain stem) and less in the hippo campus, an area exposed only to blood in the lateral ventricle, which is minimal in this model (Bederson et aI., 1995; Sehba et aI., 1999) . In the absence of hemo globin, NO can diffuse across a distance of more than 100 /-Lm to reach target cells (KeIrn, 1999) . These obser vations are consistent with the hypothesis that NO de rived from both NOS isoforms is scavenged by hemo globin immediately after SAH. A role of NO produced in perivascular nerves in neurogenic control of cerebrovas-cular tone has been observed (Jadecola et aI., 1993; Toda and Okamura, 1996) and also could be altered by SAH.
Because of its highly reactive nature, the diffusion and availability of NO at its target depends on microenviron mental conditions such as the type and amount of oxy gen-derived radicals, the pH, and concentration of tran sition metals and thiols. Furthermore, the nature of the final product of NO metabolism depends on local oxygen content at the time of its release and metabolism. Aerobic conditions favor production of methemoglobin and ni trate, whereas anaerobic conditions favor production of slowly dissociating nitrosylhemoglobin (KeIrn, 1999; Wennmalm et aI., 1992) .
Administration of L-NAME had a biphasic effect: an immediate physiologic response (increased BP, de creased CBF) and a delayed decrease in NO metabolite levels. In contrast, SAH was followed by immediate al terations in both physiologic parameters and NO metabo lites. Since L-NAME inhibits NO synthesis, a decrease in NO metabolites would be observed only when baseline metabolites (present before L-NAME administration) are eliminated. Nitrate is a stable compound, with a plasma half-life of 1.54 hours in rodents, and is eliminated through renal excretion (Veszelovsky et ai., 1995) . Re sidual nitrate may therefore delay observable L-NAME induced decreases in NO levels using the Griess reaction. Previous studies demonstrate that 2 hours may be re quired to observe these decreases (Salter et aI., 1996; Traystman et aI., 1995) . In contrast, the acute decrease in NO metabolites after SAH may involve scavenging of NO by subarachnoid hemoglobin, anaerobic metabolism of NO, as outlined earlier.
In preliminary experiments, we found that, unlike ni trite, nitrate does not bind hemoglobin (data not shown). Because nitrate is an oxidation product of nitrite, mea surable changes in its levels are preceded by changes in nitrite. These measurements are influenced by the time required for oxidation and accumulation of enough prod uct to observe it through the Griess reaction. This may have contributed to the observed recovery of nitrite 180 minutes after SAH, a time when nitrate levels still are reduced in brain stem and ventral convexity cortex. Nev ertheless, a significant decrease in nitrate levels in brain stem and cerebellum 10 minutes after SAH without a subsequent decrease in nitrite levels is surprising.
An additional explanation of the decrease in NO me tabolites seen after SAH could be inhibition of NOS after SAH by an unknown mechanism. However, previous studies show that L-arginine, a substrate of NOS, retains its ability to increase CBF after SAH (Kajita et aI., 1994; Takayasu et aI., 1994) , indicating that NOS activity may not be acutely decreased by SAH. In addition, as the NOS inhibitor L-NAME had no effect on NO metabolites at 40 minutes, an alternative explanation is required. In preliminary experiments using the citrulline assay, we J Cereb Blood Flow Metah. Vo/. 20. No. 3, 2000 found no effect of SAH on NOS actlVlty, affinity for substrate, or Ca+ 2 sensitivity in all five brain regions (unpublished data). The recovery of NO metabolites to baseline levels 180 minutes after SAH could indicate both increased NO production and saturation of hemoglobin. However, he moglobin binding would influence measured NO levels, making an increase difficult to detect. The NOS activity could be increased by at least three mechanisms: (1) decreased product inhibition of NO on NOS, resulting from scavenging of NO (Vickroy and Malphurs, 1995) ;
(2) activation of glutamate-activated N-methyl-o aspartate receptors (Love, 1999) ; or (3) increased expres sion of NOS (Sayama et aI., 1998 ). An increase in NOS gene and protein expression has been demonstrated after various types of ischemia including SAH (Hino et ai., 1996; Iadecola, 1997; Sayama et aI., 1998) .
The decrease in CBF after L-NAME administration in control rats (approximately 30%) is not enough to create an ischemic hypoxic environment in the brain. In con trast, SAH induces acute cerebral ischemia. Taken to gether with our previous results, the current study sup ports the concept that acute ischemia in this setting is a multifactorial process consisting of several additive in sults such as raised ICP, decreased cerebral perfusion pressure, and acute vasoconstriction. Acute vasoconstric tion, caused in part by decreased NO availability, con tributes significantly to this process. CONCLUSION We have measured cerebral levels of NO metabolites after SAH and demonstrated significant decreases 10 minutes after the hemorrhage. We hypothesize that this decrease is a reflection of decreased NO availability that causes acute vasoconstriction after SAH and explains why NO donors are effective in reversing acute SAH induced ischemia. Decreased NO levels after SAH may result from scavenging by hemoglobin and anaerobic metabolism into nitrosylhemoglobin. These mechanisms need to be investigated further, directly by measuring the levels of nitrosylhemoglobin, and indirectly by measur ing methemoglobin after SAH.
